Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-12-25
pubmed:databankReference
pubmed:abstractText
Preclinical and clinical studies have suggested that milnacipran, a dual norepinephrine-serotonin reuptake inhibitor, may be efficacious in the treatment of fibromyalgia (FM).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0149-2918
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1988-2004
pubmed:dateRevised
2009-10-27
pubmed:meshHeading
pubmed-meshheading:19108787-Adult, pubmed-meshheading:19108787-Aged, pubmed-meshheading:19108787-Capsules, pubmed-meshheading:19108787-Constipation, pubmed-meshheading:19108787-Cyclopropanes, pubmed-meshheading:19108787-Dizziness, pubmed-meshheading:19108787-Dose-Response Relationship, Drug, pubmed-meshheading:19108787-Double-Blind Method, pubmed-meshheading:19108787-Fatigue, pubmed-meshheading:19108787-Female, pubmed-meshheading:19108787-Fibromyalgia, pubmed-meshheading:19108787-Humans, pubmed-meshheading:19108787-Male, pubmed-meshheading:19108787-Middle Aged, pubmed-meshheading:19108787-Pain, pubmed-meshheading:19108787-Pain Measurement, pubmed-meshheading:19108787-Patient Satisfaction, pubmed-meshheading:19108787-Placebos, pubmed-meshheading:19108787-Serotonin Uptake Inhibitors, pubmed-meshheading:19108787-Time Factors, pubmed-meshheading:19108787-Treatment Outcome, pubmed-meshheading:19108787-Vomiting
pubmed:year
2008
pubmed:articleTitle
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
pubmed:affiliation
Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan Medical School, Ann Arbor, Michigan 48106, USA. dclauw@umich.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study